Machado-Alba Jorge Enrique, Medina-Morales Diego Alejandro, Echeverri-Cataño Luis Felipe
a Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia , Universidad Tecnológica de Pereira-Audifarma S.A ., Pereira , Colombia.
Expert Opin Drug Saf. 2017 Feb;16(2):133-137. doi: 10.1080/14740338.2017.1273346. Epub 2016 Dec 26.
Objetive: This study evaluated the results of treatment adherence scales in two cohorts of patients with diabetes mellitus treated either with human or analogue insulins.
A cohort study was conducted in diabetes mellitus patients older than 18 that were being treated with human or analogue insulins. Two instruments were applied to each patient [medication possession ratio, Morisky-Green test] to evaluate treatment adherence.
A total of 238 patients, were included. The majority (69.4%) of the subjects had human insulin and 30.6% had insulin analogue prescriptions. Out of the total, 163 (68.5%) cases were classified as adherent to therapy, according to the type of insulin, as follows: 69.9% for conventional and 65.3% for analogues; without differences between the groups (CI95%:0.450-1.458). The adherence to treatment was more probable in patients with elementary-secondary education (OR:2.341; CI95%:1.199-4.568) and less probable for those in the age range of 31-45 years (OR:0.427; CI95%:0.187-0.971).
The results of this study show that there are no significant statistical differences in adherence when comparing human with analogue insulin therapy. Strategies to improve treatment adherence are particularly important since they improve the clinical results.
目的:本研究评估了两组接受人胰岛素或胰岛素类似物治疗的糖尿病患者治疗依从性量表的结果。
对18岁以上接受人胰岛素或胰岛素类似物治疗的糖尿病患者进行了队列研究。对每位患者应用两种工具[药物持有率,莫利斯基-格林测试]来评估治疗依从性。
共纳入238例患者。大多数(69.4%)受试者使用人胰岛素,30.6%有胰岛素类似物处方。根据胰岛素类型,总计163例(68.5%)病例被分类为治疗依从,具体如下:传统胰岛素为69.9%,类似物为65.3%;两组之间无差异(95%置信区间:0.450 - 1.458)。接受中小学教育的患者治疗依从性更高(比值比:2.341;95%置信区间:1.199 - 4.568),而年龄在31 - 45岁之间的患者依从性较低(比值比:0.427;95%置信区间:0.187 - 0.971)。
本研究结果表明,比较人胰岛素与胰岛素类似物治疗时,依从性无显著统计学差异。改善治疗依从性的策略尤为重要,因为它们能改善临床结果。